Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Neoplasms 94Breast Neoplasms 84Lung Neoplasms 51Prostatic Neoplasms 47Colorectal Neoplasms 37Carcinoma, Non-Small-Cell Lung 32Pancreatic Neoplasms 29Hematologic Neoplasms 23Lymphoma 19Brain Neoplasms 19Stomach Neoplasms 18Ovarian Neoplasms 18Urinary Bladder Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Leukemia, Myeloid, Acute 15Esophageal Neoplasms 15Carcinoma, Hepatocellular 15Melanoma 14Liver Neoplasms 14Leukemia 13Head and Neck Neoplasms 13Uterine Cervical Neoplasms 12Lymphoma, Non-Hodgkin 12Leukemia, Lymphocytic, Chronic, B-Cell 12Disease 12Carcinoma, Renal Cell 12Kidney Neoplasms 11Colonic Neoplasms 11Glioma 10

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Inflammatory Bowel Diseases × 30 days × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡